Training and Education

Nemera’s preservative-free multi-dose eyedropper approved in Brazil for Aché’s NSAID’s and Dry Eye formulations

Nemera is excited to announce that its multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON (Ketorolac 0,4% and 0,5%), a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat moderately severe pain...

What makes a spinout?

Universities carry out research into some of the most fundamental questions about life and the world around us, with researchers utilising specialist facilities and equipment to investigate and advance human knowledge.  This doesn’t happen overnight, and there is inherently a...

Covid-19 transmission chains in the UK traced through time and space with remarkable accuracy using genomic epidemiology

A team of scientists, led by researchers from the Universities of Oxford and Edinburgh, has analysed the first wave of the Covid-19 outbreak in the UK and produced the most fine-scaled and comprehensive genomic analysis of transmission of any...

Pioneering technique paves way for fast and cheap fabrication of rapid medical diagnostic tools

Breakthrough promises to democratise microfluidics and lab-on-a-chip technology, benefiting resource-poor countries and settings. New technology developed by the University of Bristol has the potential to accelerate uptake and development of on-chip diagnostic techniques in parts of the world where rapid...

UK Government invests £5m to develop ‘library’ of MRNA vaccines

CPI has received a £5 million investment to support the development of an mRNA ‘vaccine library’ as part of the Government’s vaccine support package announced in the Budget by the chancellor, Rishi Sunak. The vaccine library will form the basis...

Delivering real impact to the world of bioscience

Since it opened in 2019, the National Horizons Centre has quickly established itself as a vital linchpin helping drive forward the life sciences sector across the UK. Through research, partnerships and training , the National Horizons Centre, a £22.3 million...

CRYONISS EARNS COVETED MHRA QUALITY MARK

Experts in biological sample, and medicinal product, storage and logistics management, CRYONISS offers a comprehensive storage service from ambient down to vapour phase liquid nitrogen. The Cheshire-based team has a wealth of experience in supporting drug discovery projects, from early...

COVID-19 TESTING SECTOR DEMAND SET TO CONTINUE AMID VACCINE ROLLOUT

Amid the continued high demand for testing and staggered vaccine rollout, the diagnostics industry, which was valued in 2020 at $17.2bn-$19.8bn, is set to rise further in 2021 The diagnostics sector will continue to see growth in 2021 as demand...

EXPANSION OF NETPARK OFFERS SCIENCE AND TECHNOLOGY COMPANIES ROOM FOR GROWTH

The North-East Technology Park in County Durham – or NETPark as it is known – provides science, technology and engineering companies with the type of world-class laboratory, clean room and office space they require on the journey from start-up...

Research shows coronavirus can survive on healthcare uniforms for three days

Viruses similar to the strain that causes Covid-19 can survive on clothing and transmit to other surfaces for up to 72 hours, scientists at De Montfort University Leicester (DMU) have warned. In a study looking at how coronavirus behaves on...

Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery

University of Birmingham researchers are working to isolate and extract the COVID-19 encounter complex in a form that is stable enough for identification of target sites for future anti-viral drugs. The encounter complex is formed when the COVID-19 spike latches...

Automated drug discovery platform brings about paradigm change for research

Bringing a single new drug to market takes years of research and costs billions – with the COVID-19 pandemic highlighting even more how critical it is to accelerate this process. The high costs and failure rates in drug discovery...

Accurate predictions of ovarian cancer outcome possible with new classification system

The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the ‘Oxford Classic’, researchers have demonstrated that it enables the accurate prediction of patient...

Cervical cancer treatment world first at The Christie

A Stockport woman is set to become the first ever patient in the world to be entirely treated for cervical cancer using a state-of-art radiotherapy treatment at The Christie NHS Foundation Trust. Karen Hall, 57, will be treated using the...

Freedom to Operate – Understanding the Risks

There are many factors to be considered for a project developing a new product or process, but the ability to carry out commercial plans without infringing third party patent rights (freedom to operate, or FTO) should not be overlooked. Patent...

Legal Cannabis Market in Europe Set to be Worth €3.2 billion by 2025

The European cannabis market is forecast to grow with a compound annual growth rate (CAGR) of 67.4% to reach €3.2 billion by 2025, a new report has found. The European Cannabis Report: 6th Edition, released by global cannabis industry consultants,...

SCOTTISH BIOTECH COMPANY SECURES FUNDING FOR NEW CORONAVIRUS RESEARCH

Company’s R&D programme expanded with additional focus on antiviral properties of cyanobacteria Industry and academia collaboration funded by Medical Research Scotland ScotBio, a fast growing Scottish biotech business, is expanding its R&D programme to explore the potential of...

RCSI researchers discover new way to halt excessive inflammation

RCSI researchers have discovered a new way to ‘put the brakes’ on excessive inflammation by regulating a type of white blood cell that is critical for our immune system. The discovery has the potential to protect the body from unchecked...

INEOS donates £100m to new institute designed to fight antimicrobial resistance

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from INEOS. INEOS, one of the world’s largest manufacturing companies, and the University of Oxford are launching a...

Clinical trials for gene and cell therapies

In early 2020, the Cell and Gene Therapy Catapult (CGTC) reported that there were 127 ongoing trials in advanced therapy medicinal products (ATMP) in the UK. This represented 12 percent of trials globally, helping to position the UK as...

Results of MDMA treatment trial for alcohol use disorder published

Awakn Life Sciences Inc. announces today the publication of results from its CMO Dr. Ben Sessa’s Bristol Imperial MDMA in Alcoholism (BIMA) trial, an open-label safety, tolerability and proof-of-concept study investigating the potential role for MDMA therapy in treating...

Zotefoams hosts virtual opening of new £23million plant in Poland

Over 140 customers from 21 countries today attended the virtual opening of Zotefoams’ new state-of-the-art plant located in Brzeg in south-west Poland. In a key strategic move to increase global capacity and optimise service levels for many customers in...

How can you prevent weak maths skills hindering student performance?

An increasing number of students are struggling to keep up with the maths content in the crucial first months of their degree, despite the measures lecturers are taking to continually adapt their teaching to try and meet the increasingly...

LAUDA to expand its portfolio with new LAUDA Versafreeze product line

LAUDA – Experts In Thermal Control And Measurement Providing Innovative Solutions For Thermal Process Control, Chilled Water Applications, Water Baths, Freezers, Incubators, Shakers, Stills, Tensiometers, Viscometers And Contact Angle Measurement. LAUDA, the world market leader in temperature control equipment and...

BioScience Today Launches Digital Packages to Support Companies During the COVID-19 Pandemic

As the Bio-Life science industry continues to be impacted by the COVID-19 pandemic, it is has become even more vital for companies to sustain their presence during these challenging times. Since the COVID-19 pandemic began in March 2020, BioScience...

Zotefoams’ ZOTEK® F foam chosen by InsulFab for safe and effective delivery of COVID-19 vaccine

High-performance closed cell, crosslinked fluoropolymer foam helps ensure safe and secure transportation of ultra-cold chain vaccine As part of the USA’s Operation Warp Speed (OWS) initiative to combat the COVID-19 pandemic, Texas, USA-based InsulFab has harnessed the unique properties...

Data science beginning to drive healthcare

Teesside University’s £22m National Horizons Centre opened in September 2019 with two objectives, to drive research into bioprocessing, digital and health, and to plug the yawning skills gap. Research, teaching and enterprise are its watchwords. The work of the National...

Prof. James Leiper, Associate Medical Director at the British Heart Foundation, looks at the future of heart and circulatory disease research

“There’s a lot of very exciting cardiovascular research going on at the moment which the BHF is heavily investing in – from stem cell therapy and regenerative medicine to identifying genes that could be linked to heart and circulatory...

HEART DISEASE RESEARCHERS SET TO WORK WITH THE NOBEL PRIZE-WINNING GENETIC SCISSORS

By Dr Leanne Grech, Research Engagement Officer at the British Heart Foundation We can all agree that 2020 has been a difficult year, but a silver lining was two women winning the Nobel Prize in Chemistry for developing the tools to...

INDUSTRY-ACADEMIA PARTNERSHIP LAUNCHES ONE STEP MANUFACTURING PROCESS FOR PHARMACEUTICAL DOSAGE FORMS

Cubi-Tech Extrusion Limited, a Cubic Pharmaceuticals Ltd company, puts an end to some of the problems inherent in pharmaceuticals production. Process efficiency and continuous manufacturing are certainly hot topics in the pharmaceutical industry right now, and with good reason. Global population...